Burzynski Research Institute (BZYR) Prepaid Assets (2017 - 2025)
Burzynski Research Institute (BZYR) posted Prepaid Assets of $100.0 for Q4 2025, down 75.0% sequentially from $400.0 in Q3 2025, and little changed YoY from $100.0 in Q4 2024.
Burzynski Research Institute (BZYR) Prepaid Assets (2017 - 2025) Analysis & Trends
Burzynski Research Institute has reported Prepaid Assets for 9 years, with the latest figure at $100.0 in Q4 2025.
- Quarterly Prepaid Assets changed 0.0% year-over-year to $100.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $100.0 (changed 0.0% YoY) and the FY2024 annual result came in at $1000.0, changed 0.0% from the prior year.
- Prepaid Assets retreated to $100.0 in Q4 2025 per BZYR's latest filing, from $400.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1415.0 in Q2 2021 and troughed at $100.0 in Q4 2022.
- A 5-year average of $647.26 and a median of $700.0 in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2021 and 2022: Prepaid Assets slumped 95.46% in 2021, then surged 43.06% in 2022.
- Over 5 years, Prepaid Assets stood at $974.0 in 2021, then slumped by 89.73% to $100.0 in 2022, then changed by 0.0% to $100.0 in 2023, then changed by 0.0% to $100.0 in 2024, then changed by 0.0% to $100.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $100.0, $400.0, and $700.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Burzynski Research Institute | 1.31 Mn | 1.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 100.00 |
| Aug 31, 2025 | 400.00 |
| May 31, 2025 | 700.00 |
| Nov 30, 2024 | 100.00 |
| Aug 31, 2024 | 400.00 |
| May 31, 2024 | 700.00 |
| Feb 29, 2024 | 1,000.00 |
| Nov 30, 2023 | 100.00 |
| Aug 31, 2023 | 400.00 |
| May 31, 2023 | 700.00 |
| Feb 28, 2023 | 1,000.00 |
| Nov 30, 2022 | 100.00 |
| Aug 31, 2022 | 400.00 |
| May 31, 2022 | 700.00 |
| Feb 28, 2022 | 1,279.00 |
| Nov 30, 2021 | 974.00 |
| Aug 31, 2021 | 936.00 |
| May 31, 2021 | 1,415.00 |
| Feb 28, 2021 | 894.00 |
| Nov 30, 2020 | 1,073.00 |